A detailed history of Goldentree Asset Management LP transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Goldentree Asset Management LP holds 2,304,993 shares of TEVA stock, worth $39.5 Million. This represents 3.78% of its overall portfolio holdings.

Number of Shares
2,304,993
Previous 2,485,650 7.27%
Holding current value
$39.5 Million
Previous $40.4 Million 2.83%
% of portfolio
3.78%
Previous 4.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$15.81 - $18.96 $2.86 Million - $3.43 Million
-180,657 Reduced 7.27%
2,304,993 $41.5 Million
Q2 2024

Aug 14, 2024

BUY
$12.78 - $17.4 $5.46 Million - $7.43 Million
427,000 Added 20.74%
2,485,650 $40.4 Million
Q1 2024

May 28, 2024

SELL
$10.67 - $14.43 $19.4 Million - $26.2 Million
-1,816,350 Reduced 46.87%
2,058,650 $29 Million
Q4 2023

Feb 14, 2024

BUY
$8.12 - $10.63 $31.5 Million - $41.2 Million
3,875,000 New
3,875,000 $40.5 Million
Q4 2022

Feb 14, 2023

BUY
$7.95 - $9.48 $19.8 Million - $23.6 Million
2,493,348 New
2,493,348 $22.7 Million
Q2 2022

Aug 15, 2022

BUY
$7.38 - $10.4 $28.2 Million - $39.8 Million
3,822,965 New
3,822,965 $28.7 Million
Q2 2019

Aug 14, 2019

SELL
$8.12 - $15.72 $8.22 Million - $15.9 Million
-1,012,580 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$15.58 - $20.01 $13.1 Million - $16.8 Million
-839,055 Reduced 45.31%
1,012,580 $15.9 Million
Q4 2018

Feb 14, 2019

BUY
$14.59 - $23.84 $27 Million - $44.1 Million
1,851,635 New
1,851,635 $28.6 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Goldentree Asset Management LP Portfolio

Follow Goldentree Asset Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldentree Asset Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Goldentree Asset Management LP with notifications on news.